AmerisourceBergen Corporation (Holding Co) (ABC) Receiving Somewhat Positive Media Coverage, Study Shows
Media stories about AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) have been trending somewhat positive on Wednesday, Accern Sentiment reports. The research group identifies negative and positive press coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. AmerisourceBergen Corporation (Holding Co) earned a news impact score of 0.13 on Accern’s scale. Accern also assigned headlines about the company an impact score of 45.2331136050558 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.
Here are some of the headlines that may have impacted Accern Sentiment’s rankings:
- Missouri attorney general demands opioid distributor records (marketbeat.com)
- AmerisourceBergen (ABC) Q4 Earnings: Will it Disappoint? – Nasdaq (nasdaq.com)
- Opioid Makers Faces Heat From Investors With $1.3 Trillion (bloomberg.com)
- Metropolitan Bank Holding Corp. Launches Initial Public Offering of Common Stock (abc-7.com)
- Aetna-CVS talks show Amazon’s shadow looming over health care industry – Crain’s Detroit Business (crainsdetroit.com)
AmerisourceBergen Corporation (NYSE ABC) opened at 76.95 on Wednesday. AmerisourceBergen Corporation has a one year low of $68.38 and a one year high of $97.85. The stock has a market cap of $16.86 billion, a P/E ratio of 20.05 and a beta of 0.96. The company’s 50-day moving average price is $80.92 and its 200-day moving average price is $85.91.
AmerisourceBergen Corporation (Holding Co) (NYSE:ABC) last announced its quarterly earnings data on Thursday, August 3rd. The company reported $1.43 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.37 by $0.06. The business had revenue of $38.71 billion during the quarter, compared to the consensus estimate of $39.13 billion. AmerisourceBergen Corporation (Holding Co) had a net margin of 0.56% and a return on equity of 56.07%. The firm’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same quarter last year, the firm earned $1.37 earnings per share. Analysts forecast that AmerisourceBergen Corporation will post $5.88 EPS for the current fiscal year.
Several equities research analysts have issued reports on the company. Jefferies Group LLC set a $85.00 price target on AmerisourceBergen Corporation (Holding Co) and gave the stock a “hold” rating in a research note on Sunday. Needham & Company LLC set a $93.00 price objective on AmerisourceBergen Corporation (Holding Co) and gave the stock a “buy” rating in a report on Tuesday, October 24th. Leerink Swann set a $90.00 price objective on AmerisourceBergen Corporation (Holding Co) and gave the stock a “buy” rating in a report on Monday, August 7th. ValuEngine upgraded AmerisourceBergen Corporation (Holding Co) from a “hold” rating to a “buy” rating in a report on Tuesday. Finally, TheStreet downgraded AmerisourceBergen Corporation (Holding Co) from a “b” rating to a “c+” rating in a report on Thursday, August 3rd. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, six have issued a buy rating and one has given a strong buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $91.13.
In other news, insider Peyton R. Howell sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $80.00, for a total transaction of $1,600,000.00. Following the transaction, the insider now directly owns 57,135 shares of the company’s stock, valued at $4,570,800. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, insider Gina Clark sold 1,273 shares of the firm’s stock in a transaction that occurred on Thursday, August 17th. The stock was sold at an average price of $80.94, for a total transaction of $103,036.62. Following the transaction, the insider now directly owns 10,830 shares in the company, valued at $876,580.20. The disclosure for this sale can be found here. In the last three months, insiders sold 64,728 shares of company stock valued at $5,215,143. 27.40% of the stock is owned by insiders.
AmerisourceBergen Corporation (Holding Co) Company Profile
AmerisourceBergen Corporation is a pharmaceutical sourcing and distribution services company. The Company’s segments include Pharmaceutical Distribution and Other. The Company provides services to healthcare providers, and pharmaceutical and biotech manufacturers. As of June 30, 2016, the Pharmaceutical Distribution segment consists of two operating segments, including the operations of AmerisourceBergen Drug Corporation (ABDC) and AmerisourceBergen Specialty Group (ABSG), which distributes specialty drugs to their customers.
Receive News & Ratings for AmerisourceBergen Corporation (Holding Co) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen Corporation (Holding Co) and related companies with Analyst Ratings Network's FREE daily email newsletter.